Loading organizations...
§ Private Profile · El Segundo, CA, USA
Varda is a technology company.
Varda Space Industries develops and operates in-space manufacturing platforms, producing materials in microgravity for return to Earth. The company focuses on pharmaceuticals and other complex substances, leveraging space conditions to enhance properties like small molecule crystallization. Their approach integrates specialized spacecraft with autonomous W-Series reentry capsules, enabling precise orbital manufacturing and safe retrieval.
Founded in January 2021 by Will Bruey and Delian Asparouhov, Varda emerged from the insight that certain materials benefit from microgravity processing. Bruey, a former SpaceX electrical engineer, provides aerospace expertise, while Asparouhov, associated with Founders Fund, contributes strategic acumen. This blend of space hardware and venture capital background underpins their industrialization of space.
The company primarily serves the pharmaceutical industry, offering a novel method for producing high-quality drug crystals challenging to synthesize on Earth. Beyond pharmaceuticals, Varda's capabilities could extend to sectors seeking unique material properties. Varda envisions a future where space-based factories routinely produce superior products for many Earth-bound industries, marking significant manufacturing evolution.
Varda has raised $500.0M across 6 funding rounds.
Varda has raised $500.0M in total across 6 funding rounds.
Varda Space Industries is a space technology company that builds autonomous spacecraft for in-space manufacturing, primarily targeting pharmaceuticals processed in microgravity and returned to Earth via reentry capsules.[1][2][4][5] It serves biopharmaceutical firms and government agencies like the US Department of Defense (DoD), solving the challenge of producing superior drug crystals and materials impossible in Earth's gravity, such as novel polymorphs for cancer, diabetes, and chronic pain treatments.[1][3][4] Varda's Winnebago Series (W-Series) capsules handle end-to-end operations—sample preparation, orbital manufacturing, and safe reentry—while also enabling hypersonic testing for military applications.[1][2] Growth includes multiple missions (W-1 in 2023, W-3 in March 2025), a DoD contract through 2028, partnerships like SSPC for crystallization models, and ~$5M in seed funding by May 2025.[1][4]
Varda Space Industries was founded in January 2021 by Will Bruey, a former SpaceX electrical engineer, and Delian Asparouhov, a Founders Fund associate, with backing from investors like Khosla Ventures, Founders Fund, Lux Capital, and General Catalyst.[2][4][5] The idea emerged from leveraging cheap access to space via reusable rockets to manufacture high-value Earth products in microgravity, starting with pharmaceuticals but expanding to hypersonics and fiber optics.[2][5] Early traction included contracts with Rocket Lab (2021) and SpaceX for launches, the first W-1 mission on Falcon 9 in June 2023 demonstrating pharmaceutical processing, and a 2025 Air Force Prometheus program for hypersonic tests.[1][4]
Varda rides the low Earth orbit (LEO) economy boom, fueled by falling launch costs from reusable rockets, enabling microgravity as an industrial tool for pharma, materials, and defense.[5][6][7] Timing aligns with surging demand for in-orbit manufacturing amid ISS retirement and private stations' rise, where Varda leads by solving reentry logistics—a key bottleneck for competitors like SpacePharma or Space Tango.[3][6] Market forces include high pharma margins, DoD hypersonic needs, and trends in zero-g R&D for semiconductors/biotech; Varda influences the ecosystem by standardizing orbital factories, accelerating commercial space infrastructure, and proving space's terrestrial ROI.[1][6][7]
Varda is positioned to scale W-Series missions, expand pharma partnerships (e.g., via SSPC models), and deepen DoD ties through 2028, potentially hitting production cadence with more launches.[1][4] Trends like LEO stations growth and microgravity demand will propel it, evolving its role from pioneer to infrastructure provider in a multi-billion orbital economy.[6][7] As reentry tech matures, Varda could unlock mass-market space manufacturing, directly benefiting Earth lives—transforming the simple vision of space as industry's next frontier into reality.[2][5]
Varda has raised $500.0M across 6 funding rounds. Most recently, it raised $190.0M Series C in July 2025.
Varda has raised $500.0M in total across 6 funding rounds.
Varda's investors include Ravi Tanuku, Shrug Capital, 01 Advisors, 11k Ventures, 8VC, Abstract Ventures, Afore Capital, Also Capital, Alumni Ventures, Andreessen Horowitz, Anorak Ventures, Ballistic Ventures.